Literature DB >> 30725243

Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases.

Hanan Polansky1, Edan Itzkovitz2, Adrian Javaherian2.   

Abstract

The Editor of this journal has published this Expression of Concern to alert readers that, following publication of the article [1], it came to light that there were undeclared competing interests that have a direct impact on the article and the strength of its findings. In addition, post publication peer review has indicated that the conclusions may not be supported by the results due to methodological flaws in the study. Pending further investigation of these concerns, further editorial action may be taken. The authors have not responded to any correspondence about this Expression of Concern.

Year:  2019        PMID: 30725243      PMCID: PMC6365573          DOI: 10.1186/s40169-019-0222-0

Source DB:  PubMed          Journal:  Clin Transl Med        ISSN: 2001-1326


Expression of Concern: Clin Trans Med (2016) 5:40 10.1186/s40169-016-0121-6

The Editor of this journal has published this Expression of Concern to alert readers that, following publication of the article [1], it came to light that there were undeclared competing interests that have a direct impact on the article and the strength of its findings. In addition, post publication peer review has indicated that the conclusions may not be supported by the results due to methodological flaws in the study. Pending further investigation of these concerns, further editorial action may be taken. The authors have not responded to any correspondence about this Expression of Concern.
  1 in total

1.  Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases.

Authors:  Hanan Polansky; Edan Itzkovitz; Adrian Javaherian
Journal:  Clin Transl Med       Date:  2016-10-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.